Written by Dr. Reema Hammoud, AVP, clinical pharmacy The opioid epidemic in this country has left prescribers looking for pain treatment alternatives, and one emerging option has been anticonvulsants known as gabapentinoids (e.g. gabapentin and Lyrica®, also known as pregabalin). With a need for options, and CDC guidelines recommending gabapentinoids as first-line agents for neuropathic […]
August 23, 2019
Go to post